Novel uses of mammalian ccr6 receptors and related reagents

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A01K 67/027 (2006.01) A61K 38/17 (2006.01) A61P 29/00 (2006.01) A61P 37/00 (2006.01) C07K 14/52 (2006.01) C07K 14/715 (2006.01) C07K 16/24 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2384076

Compositions and methods for using mammalian CCR6 and MIP-3.alpha. proteins to treat an abnormal physiological condition in an individual. The methods comprise administering a therapeutically effective amount of CCR6 or MIP- 3.alpha. alone, or in combination with other therapeutic reagents; or a CCR6 or MIP-3.alpha. antagonist. Genetically-engineered animals and their use as models of molecular mechanism are also provided.

L'invention porte sur des compositions et procédés d'utilisation de protéines CCR6 et MIP-3.alpha. pour le traitement d'un état physiologique anormal chez un individu. Ledit procédé consiste à administrer une dose à efficacité thérapeutique de CCR6 ou de MIP-3.alpha. seule ou associée à d'autres réactifs thérapeutiques; ou un antagoniste du CCR6 ou du MIP-3.alpha.. L'invention porte en outre sur des animaux transgéniques et leur utilisation comme modèles de mécanismes moléculaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel uses of mammalian ccr6 receptors and related reagents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel uses of mammalian ccr6 receptors and related reagents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel uses of mammalian ccr6 receptors and related reagents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1647068

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.